Seegene
Seeplex® System
Seeplex® is a breakthrough multiplexing PCR technology that enables a new standard in simultaneous multi-pathogen detection. Seegene applies its novel and proprietary Seeplex® system utilizing its DPO™ (Dual Priming Oligonucleotide) technology to create multi-pathogen tests delivering maximum specificity, reproducibility and sensitivity.
DPO™ Technology
DPO™ technology is a fundamental tool for blocking extension of non-specifically primed templates generating consistently high specificity. The strength and utility of this DPO™ technology can be successfully incorporated into molecular diagnostics systems such as multiplex diagnostics and SNP genotyping systems.
Pathogen detection
Respiratory pathogen detection
- Seeplex® Influenza A/B OneStep Typing
- Seeplex® RV12 ACE Detection
- Seeplex® RV15 ACE Detection
- Seeplex® RV15 One Step ACE Detection
- Seeplex® RV7 Detection
- Seeplex® PneumoBacter ACE Detection
STD pathogen detection
- Seeplex® STI Master ACE Detection
- Seeplex® STD ACE Detection Series
HPV detection
- Seeplex® HPV6 Genotyping
- Seeplex® HPV4 ACE Screening
TB detection
- Seeplex® MTB/NTM ACE Detection
- Seeplex® MTB nested ACE Detection
- Seeplex® MTB ACE Detection
HSV detection
- Seeplex® HSV2 ACE Detection
Meningitis bacteria and virus detection
- Seeplex® Meningitis ACE Detection
Diarrhea bacteria and virus detection
- Seeplex® Diarrhea ACE Detection
Drug resistance detection
- Seeplex® VRE ACE Detection
- Seeplex® MRSA ACE Detection
- Seeplex® ClaR-H.pylori ACE Detection
- Seeplex® HBV Lami-resistant ACE
- Seeplex® GBS-R ACE Detection
SNP detection
- Seeplex® MTHFR Genotyping
- Seeplex® CYP2C19 ACE Genotyping
- Seeplex® ApoE Genotyping
Somatic mutation detection
- Seeplex® Leukemia AML1/ETO ACE
- Seeplex® Leukemia BCR/ABL
- Seeplex® Leukemia PML/RARa
- Seeplex® BRAF V600E ACE Detection
- Seeplex® BRAF ACE Detection
- Seeplex® JAK2 Genotyping
- Seeplex® FLT3Genotyping
Seeplex® Applications Overview |
[PDF 20KB] |
Seeplex® Catalogue |
[PDF 40000KB] |
Respiratory Pathogen Detection |
[PDF 2200KB] |
STD Pathogen Detection |
[PDF 580KB] |
HPV and STI Pathogen Detection |
[PDF 300KB] |
Diarrhea Pathogen Detection |
[PDF 1580KB] |
Meningitis Pathogen Detection |
[PDF 1120KB] |
GBS-R Detection |
[PDF 5190KB] |
DPO™ Technology |
[PDF 260KB] |
DPO™ Technology |
Play |
Contact
Baselstr. 55
CH-4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
info@buhlmannlabs.ch
| Your local distributor Order About us Job opportunities |
Search
News
The recently launched EntroGen BRAF (V600E/K/D) test, that can be run on your real-time PCR instrument, is now CE-IVD marked
The EntroGen BRAF (V600E/K/D) test is a very useful tool for the detection of important mutations found in melanoma, because it detects, beside the V600E more
INFINITI KRAS-BRAF study from the Basel Institut of Pathology published in the Diagnostic Molecular Pathology journal.
New publication about the INFINITI KRAS assay in the Journal Diagn Mol Path 21/1 2012 14-23, Bihl et al. In this study from the Institute of Pathology at more
Recent publications on BÜHLMANN calprotectin assays
Three very interesting new papers have been published recently. Manz et al. describes the quality and usefulness of the BÜHLMANN calprotectin ELISA in an more
NEW OWN CALPROTECTIN REIMBURSEMENT POSITION IN SWITZERLAND
BÜHLMANN is very proud to announce that the calprotectin determination in stool starting from January 1st 2012, has an official new position in the reimb more
BÜHLMANN Core | BÜHLMANN Molecular | BÜHLMANN Medical | Customer Relations | About Us |
Contact |
